Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 482 (RNA5SP482) is a human processed pseudogene derived from the highly conserved 5S ribosomal RNA gene. Unlike functional 5S rRNA, which is a small RNA integral to ribosome structure and function[1][3][7], pseudogenes like RNA5SP482 typically result from duplication or retrotransposition events and contain disabling mutations or deletions that prevent them from producing functional RNA molecules[4][8]. These pseudogenes lack known coding or regulatory capability and are not directly involved in therapeutic targeting. However, in broader genomic studies, pseudogene expression has occasionally been linked to disease regulation or cancer through non-coding RNA effects, but there is no evidence for such effects specifically for RNA5SP482[6]. This entry describes a non-functional, non-protein-coding rRNA pseudogene with no known direct role in disease, drug interaction, or actionable biological process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 482 (RNA5SP482).